Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Pharm-country    crawled date : 2022 - 02 - 15    save search

Avenue Therapeutics Stock Trading Halted TodayFDA Advisory Committee to review IV tramadol New Drug Application
Published: 2022-02-15 (Crawled : 15:30) - biospace.com/
ATXI | $0.0949 -29.18% -41.2% 12M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

new drug day fda application drug therapeutics oda
Amarin to Report Fourth Quarter and Full Year 2021 Financial Results And Host Conference Call on March 1, 2022
Published: 2022-02-15 (Crawled : 14:30) - biospace.com/
AMRN | News | $0.8844 0.13% 0.12% 660K twitter stocktwits trandingview |
Health Technology
| | O: 0.59% H: 4.97% C: 4.68%

financial results conference report results
PDS Biotech Announces Clinical Trial with Mayo Clinic to Study PDS0101 in Early Stage Pre-Metastatic- HPV-Associated Head and Neck Cancer
Published: 2022-02-15 (Crawled : 14:30) - biospace.com/
PDSB | $3.26 1.88% 1.84% 450K twitter stocktwits trandingview |
Health Technology
| | O: 2.78% H: 4.42% C: -1.71%

pds0101 ces hpv trial cancer head and neck biotech iot
Brainstorm Cell Therapeutics Announces Grant of a New Brazilian Patent Covering Methods of Manufacturing NurOwn®
Published: 2022-02-15 (Crawled : 13:30) - biospace.com/
BCLI A | $0.5339 1.7% 1.67% 190K twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 5.3% C: 3.31%

nurown patent therapeutics cel brazil grant granted
TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Published: 2022-02-15 (Crawled : 13:30) - biospace.com/
TGTX | $13.99 -1.83% -1.86% 2.7M twitter stocktwits trandingview |
Health Technology
| | O: 2.51% H: 8.21% C: 6.84%

america multiple sclerosis treatment als trials research trial therapeutics presentation sclerosis phase 3
NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2021
Published: 2022-02-15 (Crawled : 12:30) - biospace.com/
NNVC | $1.15 0.88% 0.0% 14K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 8.18% C: 4.09%

report
Gainers vs Losers
62% 38%

Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M twitter stocktwits trandingview |
Consumer Services

BOF | $1.99 70.09% 41.21% 110M twitter stocktwits trandingview |

ILAG | $0.51 6.03% 40.62% 1.7M twitter stocktwits trandingview |

LICN | $0.941 68.04% 40.49% 15M twitter stocktwits trandingview |

AMST | $3.31 65.5% 39.58% 70M twitter stocktwits trandingview |
Technology Services

MTC | $3.615 61.38% 38.04% 9.3M twitter stocktwits trandingview |
Technology Services

WIMI | $1.15 58.53% 36.92% 19M twitter stocktwits trandingview |
Technology Services

AIH | $0.45 12.5% 30.92% 320K twitter stocktwits trandingview |
Health Services

MULN | News | $3.78 38.46% 27.78% 13M twitter stocktwits trandingview |
Information

RILY | $29.86 37.48% 27.26% 12M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.